Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity

Biochemical Journal

Volumn 353, Issue 3, 2001, Pages 569-578

  Scheidegger, P ^a   Weiglhofer, W ^a   Suarez, S ^a   Console, S ^a   Waltenberger, J ^a   Pepper, M S ^a   Jaussi, R ^a   Ballmer Hofer, K ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Angiogenesis; HIV TAT; Signal transduction; VEGF receptor

Indexed keywords

AMINO ACID; BASIC FIBROBLAST GROWTH FACTOR; CHIMERIC PROTEIN; COLLAGEN GEL; MITOGEN ACTIVATED PROTEIN KINASE; THIOREDOXIN; TRANSACTIVATOR PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL GROWTH; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL LINE; CHICKENS; CLONING, MOLECULAR; DNA PRIMERS; DOGS; ENDOTHELIAL GROWTH FACTORS; GENE PRODUCTS, TAT; HIV; HUMANS; LYMPHOKINES; MOLECULAR MIMICRY; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); CHIMAERIFORMES; GALLUS GALLUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0035252708     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3530569     Document Type: Article

References (51)

1. Blood vessel formation: What is its molecular basis?
2. Signaling vascular morphogenesis and maintenance
3. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells
4. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
5. Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies
6. Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor
7. Angiogenesis and tumor metastasis
8. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha
9. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin
10. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
11. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
12. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
13. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for FIk-1/KDR activation
14. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
15. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
16. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
17. Neovasculature induced by vascular endothelial growth factor is fenestrated
18. Vascular endothelial growth factor induces endothelial fenestrations in vitro
19. Vascular endothelial growth factor and its receptors
20. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the tins family
21. Identification of a new endothelial cell growth factor receptor tyrosine kinase
22. Endothelial receptor tyrosine kinases involved in angiogenesis
23. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
24. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
25. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
26. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
27. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
28. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells
29. HIV-tat protein is a heparin-binding angiogenic growth factor
30. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
31. Angiogenic properties of human immunodeficiency virus type 1 Tat protein
32. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
33. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases and components of local adhesion in Kaposi's sarcoma cells
34. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1
35. HIV-1 and Kaposi's sarcoma
36. The enigmas of Kaposi's sarcoma
37. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
38. Permanent cell line expressing human factor VIII-related antigen established by hybridization
39. Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current
40. Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs
41. Tumor-promoting phorbol esters induce angiogenesis in vitro
42. The attractions of proteins for small molecules and ions
43. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
44. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase
45. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
46. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro
47. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
48. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
49. Coupling herpesvirus to angiogenesis
50. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
51. Efficiency of signalling through cytokine receptors depends critically on receptor orientation